Related Experiment Videos
Elastic liposomes mediated transcutaneous immunization against Hepatitis B.
Dinesh Mishra1, Vaibhav Dubey, Abhay Asthana
1Pharmaceutics Research Laboratory, Department of Pharmaceutical Sciences, Dr. Hari Singh Gour University, Sagar 470003, India. dineshdops@yahoo.com
Vaccine
|April 8, 2006
Summary
Elastic liposomes enhance transcutaneous immunization by improving antigen delivery through the skin. This novel vaccine delivery method induces a robust immune response against Hepatitis B surface antigen (HBsAg).
Area of Science:
- Immunology
- Nanotechnology
- Dermatology
Background:
- Transcutaneous immunization faces challenges due to poor skin permeability of antigens.
- Elastic liposomes offer a promising solution for enhanced transdermal delivery of proteinaceous antigens.
Purpose of the Study:
- To evaluate Hepatitis B surface antigen (HBsAg)-loaded elastic liposomes for transcutaneous immunization.
- To assess the immune response and skin delivery efficiency of this novel formulation.
Main Methods:
- Elastic liposomes loaded with HBsAg were prepared and characterized.
- Ex vivo cellular uptake, fluorescence studies, and in vivo immunogenicity were assessed.
- Comparisons were made with intramuscular and topical non-liposomal formulations.
Main Results:
- Elastic liposomes demonstrated efficient skin permeation and biodistribution.
- Transcutaneous immunization with HBsAg-loaded elastic liposomes induced significant systemic and mucosal antibody responses.
- Higher entrapment efficiency and enhanced penetration were observed compared to controls.
Conclusions:
- Elastic liposomes are effective for transcutaneous delivery of HBsAg, enhancing vaccine immunogenicity.
- This formulation shows potential as an improved vaccine delivery system with immunoadjuvant properties.
- Efficient delivery to Langerhans cells and lymphatics supports robust immune activation.